Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 6;9(2):e70138.
doi: 10.1002/oto2.70138. eCollection 2025 Apr-Jun.

The Influence of Allergic Biomarkers in Chronic Rhinosinusitis Patients Who Underwent Functional Endoscopic Sinus Surgery

Affiliations

The Influence of Allergic Biomarkers in Chronic Rhinosinusitis Patients Who Underwent Functional Endoscopic Sinus Surgery

Lin-Hsin Tsuei et al. OTO Open. .

Abstract

Objective: This study investigates the roles of allergy, serum IgE, serum eosinophils, and tissue eosinophils in chronic rhinosinusitis (CRS) patients undergoing functional endoscopic sinus surgery (FESS). The study aims to evaluate these biomarkers in predicting disease severity and postoperative outcomes.

Study design: A retrospective cohort study.

Setting: A single academic institution.

Methods: This retrospective study enrolled patients from 2017 to 2023. Preoperative evaluations included blood tests, sinus computed tomography, nasal endoscopy, questionnaires, olfactory tests, acoustic rhinometry, saccharine transit test, and nasal bacterial culture. The number of eosinophils was counted in the surgical specimens. Postoperative evaluations were performed 3 months after surgery. The severity and outcomes of CRS were compared between allergy-positive and -negative groups, IgE-positive and -negative groups, serum eosinophil-positive and -negative groups, and eosinophilic and noneosinophilic CRS groups.

Results: Ninety-six CRS patients who underwent bilateral primary FESS were enrolled. Allergy and serum IgE showed limited predictive value for CRS outcomes. In contrast, serum eosinophils and tissue eosinophils were significantly associated with worse preoperative CRS severity, especially in olfactory dysfunction. Both biomarkers demonstrated greater postoperative improvements, with serum eosinophils showing predictive potential for ECRS (sensitivity 73.5%, specificity 78.7%).

Conclusion: Our results show that allergy testing and serum IgE levels were not reliable tools for CRS severity or outcomes, while elevated serum and tissue eosinophils were associated with worse preoperative CRS severity, particularly in olfactory dysfunction. FESS provided effective improvements in olfactory outcomes in eosinophilic CRS patients. Serum eosinophils could serve as a reliable noninvasive biomarker for predicting disease severity and surgical outcomes in ECRS patients.

Level of evidence: 3.

Keywords: IgE; allergy; chronic rhinosinusitis; eosinophil; functional endoscopic sinus surgery.

PubMed Disclaimer

Conflict of interest statement

Authors declare no potential conflicts of interest with respect to the research, authorship, or publication of this article.

Similar articles

References

    1. Tsuda T, Suzuki M, Kato Y, et al. The current findings in eosinophilic chronic rhinosinusitis. Auris Nasus Larynx. 2024;51(1):51‐60. 10.1016/j.anl.2023.08.002 - DOI - PubMed
    1. Ho J, Earls P, Harvey RJ. Systemic biomarkers of eosinophilic chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2020;20(1):23‐29. 10.1097/ACI.0000000000000602 - DOI - PubMed
    1. Shin SH, Ye MK, Park J, Geum SY. Immunopathologic role of eosinophils in eosinophilic chronic rhinosinusitis. Int J Mol Sci. 2022;23(21):13313. 10.3390/ijms232113313 - DOI - PMC - PubMed
    1. Tokunaga T, Sakashita M, Haruna T, et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study. Allergy. 2015;70(8):995‐1003. 10.1111/all.12644 - DOI - PMC - PubMed
    1. Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1‐464. 10.4193/rhin20.600 - DOI - PubMed